Z Geburtshilfe Neonatol 2017; 221(03): 122-129
© Georg Thieme Verlag KG Stuttgart · New York Prophylaxe der Neugeborenensepsis – frühe Form – durch Streptokokken der Gruppe B.
Leitlinie des BVF, BVDfK, der DGGG, DGHM, DGPI, DGPM und GNPI. (S2k-Level, AWMF-Registernummer
024/020, März 2016)
Axel Franz
,
Christoph Härtel
,
Egbert Herting
,
Sven Kehl
,
Christian Gille
,
Klaus Doubek
,
Barbara Spellerberg
,
Rolf Felix Maier
,
Klaus Vetter
,
Katarina Eglin
Literatur
1
Larsen JW,
Sever JL.
Group B Streptococcus and pregnancy: A review. Am J Obstet Gynecol 2008; 198: 440-450
2
Berner R,
Herting E,
Hufnagel M.
et al. Infektionen durch ß-hämolysierende Streptokokken der Gruppe B (GBS). DGPI-Handbuch
2013; 517-520 3
Edmond KM,
Kortsalioudaki C,
Scott S.
et al. Group B streptococcal disease in infants aged younger than 3 months: systematic
review and meta-analysis. Lancet 2012; 379: 547-556 4
Zangwill KM,
Schuchat A,
Wenger JD.
Group B streptococcal disease in the United States, 1990: Report from a multistate
active surveillance system. MMWR 1992; 41: 25-32 5
Centers for Disease Control and Prevention.
Perinatal Group B Streptococcal Disease after Universal Screening Recommendations
– United States, 2003–2005. MMWR 2007; 56: 701-705 6
Flügge K,
Siedler A,
Heinrich B.
et al. Incidence and Clinical presentation of Invasive Neonatal Group B Streptococcal
Infections in Germany. Pediatrics 2006; 117: e1139-e1149 7
Bromberger P,
Lawrence JM,
Braun D.
et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset
Group B streptococcal infection in term infants. Pediatrics 2000; 106: 244-250 8
Berner R.
Infektionen durch Gruppe-B-Streptokokken in der Neonatalperiode. Mschr Kinderheilk
2003; 151: 373-383 9
Schrag SJ,
Verani JR.
Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal
disease: experience in the United States and implications for a potential group B
streptococcal vaccine. Vaccine 2013; 31 (Suppl. 04) D20-D26 10
Verani JR,
McGee L,
Schrag SJ.
Prevention of perinatal group B streptococcal disease – revised guidelines from CDC,
2010. MMWR Recomm Rep. 2010; 59: 1-36 11
Schrag SJ,
Zywicki S,
Farley MM.
et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
N Engl J Med 2000; 342: 15-20 12
Verani JR,
Schrag SJ.
Group B streptococcal disease in infants: progress in prevention and continued challenges.
Clin Perinatol. 2010; 7: 75-92 13
Libster R,
Edwards KM,
Levent F.
et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 30:
e8-e15 14
Le Doare K,
Heath PT.
An overview of global GBS epidemiology. Vaccine 2013; 4: D7-D12 15
Brimil N,
Barthell E,
Heindrichs U.
et al. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med
Microb 2006; 296: 39-44 16
Rodriguez-Granger J,
Alvargonzalez JC,
Berardi A.
et al. Prevention of group B streptococcal neonatal disease revisited. The DEVANI
European project. Eur J Clin Microbiol Infect Dis 2012; 31: 2097-2104 17
Anthony BF,
Okada DM,
Hobel CJ.
Epidemiology of Group B Streptococcus: longitudinal observations during pregnancy.
J Infect Dis 1978; 137: 524-530 18
Centers for Disease Control and Prevention
.
Schrag S,
Gorwitz R,
Fultz-Butts K.
et al. Prevention of Perinatal Group B Streptococcal Disease. MMWR 2002; 51: 1-25
19
Martius J.
Hämolysierende Streptokokken der Gruppe B in der Geburtshilfe (Standardkommission
„Infektionen in der perinatalen Medizin“). Mitteilungen der Deutschen Gesellschaft
für Gynäkologie und Geburtshilfe 1992; 1: 46-48 20
Schuchat A,
Whitney C,
Zangwill K.
Prevention of perinatal group B streptococcal disease: A public health perspective.
MMWR 1996; 45: 1-24 21
Martius J,
Hoyme UB,
Roos R.
et al. Empfehlungen zur Prophylaxe der Neugeborenensepsis (frühe Form) durch Streptokokken
der Gruppe B. Frauenarzt 2000; 41: 689-691 22
ACOG Committee Opinion
.
Prevention of Early-Onset Group B Streptococcal Disease in Newborns. Obstet Gynecol
2002; 100: 1405-1412 23
Schrag SJ,
Zell ER,
Lynfield R.
et al. A population-based comparison of strategies to prevent early-onset Group B
streptococcal disease in neonates. N Engl J Med 2002; 347: 233-239 24
Baltimore RS,
Huie SM,
Meek JI.
et al. Early-Onset Neonatal Sepsis in the Era of Group B Streptococcal Prevention.
Pediatrics 2001; 108: 1094-1098 25
Moore MR,
Schrag SJ,
Schuchat A.
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal
disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect
Dis 2003; 3: 201-213 26
Joseph TA,
Pyati SP,
Jacobs N.
Neonatal Early-Onset Escherichia coli Disease. Arch Pediatr Adolesc Med 1998; 152:
35-40 27
Committee on Infectious Diseases and Committee on Fetus and Newborn
.
Policy Statement – Recommendations for the prevention of Perinatal Group B streptococcal
(GBS) disease. Pediatrics 2011; 128: 611-616 28
Money D,
Allen VM.
The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol
Can 2013; 35: 939-951 29
Homer CS,
Scarf V,
Catling C.
et al. Culture-based versus risk-based screening for the prevention of group B streptococcal
disease in newborns: a review of national guidelines. Women Birth 2014; 27: 46-51
30 Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal
group B streptococcal disease. RCOG Guideline.2012: 36: 1–13 Update RCOG 2013; Comments_on_RCOG_2012_GBSupdate:1–4
31
Bekker V,
Bijlsma MW,
van de Beek D.
et al. Incidence of invasive group B streptococcal disease and pathogen genotype distribution
in newborn babies in the Netherlands over 25 years: a nationswide suveillance study.
Lancet Infect Dis. 2014; 14: 1083-1089 32
Di Renzo GC,
Melin P,
Berardi A.
et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus
conference. J Matern Fetal Neonatal Med 2015; 28: 766-782 33
Rouse JD,
Goldenberg RL,
Cliver SP.
et al. Strategies for the prevention of early-onset neonatal group B streptococcal
sepsis: A decision analysis. Obstet Gynecol 1994; 83: 483-494 34
Simonsen KA,
Anderson-Berry AL,
Delair SF.
et al. Early-onset neonatal sepsis. Clinical Microbiology Reviews 2014; 27: 21-47
35
Boyer KM,
Gadzala CA,
Kelly PG.
et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset
disease: II. Predictive value of prenatal cultures J Infect Dis 1983; 148: 802-809
36
American College of Obstetricians and Gynecologists Committee on Obstetric Practice
.
ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease
in newborns. Obstet Gynecol. 2011; 117: 1019-1027 37
Fröhlicher S,
Reichen-Fahrni G,
Müller M.
et al. Serotype distribution and antimicrobial susceptibility of group B streptococci
in pregnant women: results from a Swiss tertiary centre. Swiss MedWkly 2014; 144:
w13935 10.4414/smw.2014.13935 PubMed PMID: 24652673.62 38
Thinkhamrop J,
Limpongsanurak S,
Festin MR.
et al. Infections in International Pregnancy Study: Performance of the Optical Immunoassey
Test for Detection of Group B Streptococcus. J Clinical Microbiol 2003; 41: 5288-5290
39
Atkins KL,
Atkinson RM,
Shanks A.
et al. Evaluation of Polymerase Chain Reaction for Group B Streptococcus Detection
using an improved Culture Method. Obstet Gynecol 2006; 108: 488-491 40
Natarajan G,
Johnson YR,
Zhang F.
et al. Real-Time polymerase chain reaction for the rapid detection of Group B streptococcal
colonization in neonates. Pediatrics 2006; 118: 14-22 41
Haberland CA,
Benitz WE,
Sanders GD.
et al. Perinatal screening for Group B Streptococci: Cost-Benefit analysis of rapid
polymerase chain reaction. Pediatrics 2002; 110: 471-480 42
Bergeron MG,
Ke D,
Menard C.
et al. Rapid detection of Group B streptococci in pregnant women at delivery. N Engl
J Med 2000; 343: 175-179 43
De Cueto M,
Sanchez M-J,
Sampedro A.
et al. Timing of intrapartum ampicillin and prevention of vertical transmission of
group B streptococcus. Obstet Gynecol 1998; 91: 112-114 44
Lin FYC,
Brenner RA,
Johnson YR.
et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention
of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001; 184:
1204-1210 45
Valkenburg-van den Berg AW,
Houtman-Roelofsen RL,
Oostvogel PM.
et al. Timing of group B streptococcus screening in pregnancy: a systematic review.
Gynaecol Obstet Invest 2010; 69: 174-183 46 Florindo C, Damiao V, Silvestre I et al. Epidemiological surveillance of colonising
group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal
(2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone. Euro
surveillance: bulletin Europeen sur les maladies transmissibles = European communicable
disease bulletin 2014; 19: 47
Capanna F,
Emonet SP,
Cherkaoui A.
et al. Antibiotic resistance patterns among group B Streptococcus isolates: implications
for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss medical weekly 2013;
143: w13778 48
Frohlicher S,
Reichen-Fahrni G,
Muller M.
et al. Serotype distribution and antimicrobial susceptibility of group B streptococci
in pregnant women: results from a Swiss tertiary centre. Swiss medical weekly 2014;
144: w13935 49
Ramus R,
McIntire D,
Wendel G.
Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean
section at term. Am J Obstet Gynecol 1999; 180: S85 50
ACOG Practice Bulletin
.
Prophylactic Antibiotics in Labor and Delivery. Obstet Gynecol 2003; 102: 875-882
51
Brozanski BS,
Jones JGJ,
Krohn M.
et al. Effect of a screening-based prevention policy on prevalence of early-onset
group B Streptococcal sepsis. Obstet Gynecol 2000; 95: 496-501 52
Gerards LJ,
Cats BP,
Hoogkamp-Korstanje JAA.
Early neonatal Group B streptococcal disease: degree of colonization as an important
determinant. J Infect 1985; 11: 119-124 53
Faxelius G,
Bremme K,
Kvist-Christensen K.
et al. Neonatal septicemia due to Group B streptococci - perinatal risk and outcome
of subsequent pregnancies. J Perinat Med 1988; 16: 423-430 54
Christensen KK,
Dahlander K,
Linden V.
et al. Obstetrical care in future pregnancies after fetal loss in Group B streptococcal
septicemia. A prevention program based on bacteriological and immunological follow-up.
Eur J Obstet Gynecol Reprod Biol 1981; 12: 143-150 55 Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin, Deutsche Gesellschaft
für Gynäkologie und Geburtshilfe. Betreuung des gesunden Neugeborenen im Kreißsaal
und während des Wochenbettes der Mutter. AWMF-Leitlinien-Register, Nr 024/005. http://www.uni-duesseldorf.de/AWMF/ll/index.html
56 Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin. Bakterielle Infektionen
bei Neugeborenen. AWMF-Leitlinien-Register, Nr 024/008. http://www.uni-duesseldorf.de/AWMF/ll/index.html
57
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus
and Newborn
.
Revised Guidelines for Prevention of Early-Onset Group B Streptococcal (GBS) Infection.
Pediatrics 1997; 99: 489-496 58
Ottolini MC,
Lundgren K,
Mirkinson LJ.
et al. Utility of complete blood count and blood culture screening to diagnose neonatal
sepsis in the asymptomatic at risk newborn. Pediatric Infect Dis J 2003; 22: 430-434
59
Schuchat A,
Zywicki SS,
Dinsmoor MJ.
et al. Risk Factors and Opportunities for Prevention of Early-Onset Neonatal Sepsis:
A multicenter Case-Control Study. Pediatrics 2000; 105: 21-26 60
Trijbels-Smeulders M,
Gerards LJ.
MPC et al. Epidemiology of neonatal group B streptococcal disease in The Netherlands
1997–98. Paediatr Perinat Epidemiol. 2002; 16: 334-341 61 Pintye J, Saltzman B, Wolf E et al. Risk Factors for Late-Onset Group B Streptococcal
Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic
Prophylaxis. J Pediatric Infect Dis Soc 2015 62 Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal
colonization. Cochrane Database Syst Rev. 2014 CD007467 63
Kaambwa B,
Bryan S,
Gray J.
et al. Cost-effectiveness of rapid tests and other existing strategies for screening
and anagement of early-onset group B streptococcus during labour. BJOG 2010; 117:
1616-1627 64
Martinez de Tejada B.
Antibiotic Use and Misuse during Pregnancy and Delivery: Benefits and Risks. Int.
J. Environ. Res. Public Health 2014; 11: 7993-8009 65
Håkansson S,
Källén K,
Bullarbo M.
et al. Real-time PCR-assay in the delivery suite for determination of group B streptococcal
colonization in a setting with risk-based antibiotic prophylaxis. J Matern Fetal Neonatal
Med 2014; 27: 328-332 66
Melin P.
Neonatal group B streptococcal disease: from pathogenesis to preventive strategies.
Clin Microbiol Infect 2011; 17: 1294-1303 67
Hanson L,
Vendevusse L,
Duster M.
et al. Feasibility of oral prenatal probiotics against maternal group B Streptococcus
vaginal and rectal colonization. J Obstet Gynaecol Neonatal Nurs 2014; 43: 294-304
68
Baker CJ.
The spectrum of perinatal group B streptococcal disease. Vaccine 2013; 31 (Suppl.
04) D3-D6 69
Chen VL,
Avci FY,
Kasper DL.
A Maternal Vaccine against Group B Streptococcus: Past, Present, and Future. Vaccine
2013; 31: D13-D19
